- Recommendation ID
- NG191/12
- Question
In people with suspected COVID-19-associated pulmonary aspergillosis (CAPA), what are the most accurate tests for diagnosing the infection and when should they be done?
- Any explanatory notes
(if applicable) Population: adults, young people and children who are critically ill and have, or have had, COVID-19 as part of their acute illness, and suspected CAPA. Subgroups of particular interest include young people and children, and pregnant women.
Diagnostic tests:
• any methods used to diagnose pulmonary aspergillosis (for example, CT imaging, testing of bronchoalveolar lavage, non-bronchoscopic lavage, endotracheal aspirate, sputum samples, serum assays)
Reference standard:
• lung biopsy or postmortem diagnosis
Target condition:
• CAPA
Outcomes:
• sensitivity and specificity
• positive and negative likelihood ratios
Analysis:
• optimal time of diagnostic testing
Source guidance details
- Comes from guidance
- COVID-19 rapid guideline: managing COVID-19
- Number
- NG191
- Date issued
- March 2021
Other details
Is this a recommendation for the use of a technology only in the context of research? | No |
Is it a recommendation that suggests collection of data or the establishment of a register? | No |
Last Reviewed | 17/12/2021 |